Inventor · disambiguated record
Ruth R. Wexler
Also filed as: WEXLER RUTH R · WEXLER RUTH RICHMOND
31 granted patents·4 pending applications·867 citations·filing 1984–2021
98Inventor score
Files withBRISTOL MYERS SQUIBB CO11BRISTOL MYERS SQUIBB PHARMA CO7DU PONT5DU PONT MERCK PHARMA5DU PONT PHARM CO3
Top patents by PatentIndex Score
35 records- 0197US6060491A6-membered aromatics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1998·Granted May 9, 2000·107 cites·15 claims
- 0296US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0395US6399644B1Aryl sulfonyls as factor XA inhibitorsFiled 2000·Granted Jun 4, 2002·46 cites·15 claims
- 0495US4632930AAntihypertensive alkyl-arylimidazole, thiazole and oxazole derivativesDU PONT·Filed 1984·Granted Dec 30, 1986·44 cites·45 claims
- 0594US7109339B2Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 19, 2006·88 cites·5 claims
- 0694US4576958AAntihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivativesDU PONT·Filed 1984·Granted Mar 18, 1986·31 cites·3 claims
- 0792US6689770B2Aryl sulfonyls as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 10, 2004·29 cites·18 claims
- 0891US6710058B2Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Mar 23, 2004·28 cites·23 claims
- 0990US6602871B2Thrombin or factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 5, 2003·20 cites·24 claims
- 1090US6426346B16-membered aromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jul 30, 2002·34 cites·12 claims
- 1189US5886191AAmidinoindoles, amidinoazoles, and analogs thereofDU PONT PHARM CO·Filed 1997·Granted Mar 23, 1999·48 cites·8 claims
- 1289US5310748AImidazoles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted May 10, 1994·45 cites·9 claims
- 1388US6043257AAmidinoindoles, amidinoazoles, and analogs thereofDU PONT·Filed 1998·Granted Mar 28, 2000·40 cites·7 claims
- 1487US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 1587US5166214AUse of imidazoles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1990·Granted Nov 24, 1992·41 cites·10 claims
- 1686US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 1786US6268379B1Substituted aryl hydroxamic acids as metalloproteinase inhibitorsDU PONT PHARM CO·Filed 1999·Granted Jul 31, 2001·71 cites·28 claims
- 1885US5091390ATreatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogsDU PONT·Filed 1990·Granted Feb 25, 1992·36 cites·24 claims
- 1984US6951872B2Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Oct 4, 2005·14 cites·21 claims
- 2083US6949550B2Substituted amino methyl factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 27, 2005·13 cites·40 claims
- 2178US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 2277US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 2377US6403583B1Thrombin or factor Xa inhibitorsFiled 1999·Granted Jun 11, 2002·17 cites·27 claims
- 2475US5290801ABenzimidazoles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Mar 1, 1994·56 cites·8 claims
- 2573US5318984AImidazoles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Jun 7, 1994·15 cites·21 claims
- 2664US5478830AFused-ring heterocycles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Dec 26, 1995·9 cites·12 claims
- 2762US6878710B2Bicyclic inhibitors of factor XaBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 12, 2005·2 cites·40 claims
- 2861US2016368923A1Pyrimidinones as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2959US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 3058US6790845B2Fused heterocyclic inhibitors of factor XaBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Sep 14, 2004·1 cites·37 claims
- 3154US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 3253US6365587B1Substituted aryl hydroxamic acids as metalloproteinase inhibitorsFiled 1999·Granted Apr 2, 2002·9 cites·20 claims
- 3348US2003073682A1Novel substituted aryl hydroxamic acids as metalloproteinase inhibitorsFiled 2002·Application pending·0 cites
- 3446US2017057961A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3541US4868181A1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activityDU PONT·Filed 1987·Granted Sep 19, 1989·3 cites·72 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →